Concentrix (NASDAQ:CNXC) Releases Q4 2026 Earnings Guidance

Key Points

• Concentrix lowered its Q4 2026 outlook, guiding for EPS of $2.86–$2.98 versus the $3.08 consensus estimate, and revenue of $2.4–$2.5 billion versus the $2.5 billion consensus. Full-year 2026 EPS guidance was set at $10.97–$11.09.
• Analysts broadly reduced their price targets, with targets now ranging from $26 to $45; the stock carries a consensus “Hold” rating and an average price target of $32.75.
• Shares fell 2.2% to $24.88. Concentrix also recently narrowly missed quarterly expectations, reporting $2.63 EPS and $2.46 billion in revenue, while posting a negative 13.16% net margin.

Concentrix (NASDAQ:CNXC - Get Free Report) updated its fourth quarter 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 2.860-2.980 for the period, compared to the consensus EPS estimate of 3.080. The company issued revenue guidance of $2.4 billion-$2.5 billion, compared to the consensus revenue estimate of $2.5 billion. Concentrix also updated its FY 2026 guidance to 10.970-11.090 EPS.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. Robert W. Baird decreased their price target on shares of Concentrix from $40.00 to $30.00 and set an "outperform" rating on the stock in a research note on Tuesday, June 30th. Canaccord Genuity Group dropped their target price on Concentrix from $55.00 to $45.00 and set a "buy" rating for the company in a report on Tuesday, June 30th. Barrington Research cut their target price on Concentrix from $38.00 to $30.00 and set an "outperform" rating for the company in a research report on Tuesday, June 30th. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Concentrix in a research note on Friday, July 24th. Finally, Bank of America dropped their price objective on Concentrix from $32.00 to $26.00 and set a "neutral" rating for the company in a research note on Tuesday, June 30th. Three analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $32.75.

Concentrix Trading Down 2.2%

NASDAQ:CNXC traded down $0.57 during trading hours on Tuesday, hitting $24.88. The stock had a trading volume of 2,750,696 shares, compared to its average volume of 1,626,106. The business's 50 day moving average is $26.99 and its 200-day moving average is $26.59. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.18 and a current ratio of 1.18. The company has a market cap of $1.52 billion, a price-to-earnings ratio of -1.17, a P/E/G ratio of 0.50 and a beta of 0.47. Concentrix has a one year low of $19.12 and a one year high of $49.37.

Concentrix (NASDAQ:CNXC - Get Free Report) last announced its quarterly earnings results on Monday, June 29th. The company reported $2.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.64 by ($0.01). The firm had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.47 billion. Concentrix had a negative net margin of 13.16% and a positive return on equity of 19.82%. Concentrix's quarterly revenue was up 1.9% on a year-over-year basis. During the same period last year, the firm earned $2.70 EPS. Sell-side analysts anticipate that Concentrix will post 9.67 EPS for the current fiscal year.

About Concentrix

Concentrix Corporation is a global technology and services company that helps organizations manage customer experience, business operations and digital transformation. Its offerings include customer care, technical support, sales and marketing services, back-office support, analytics, artificial intelligence and automation solutions.

The company serves clients across industries such as technology and consumer electronics, retail, banking and financial services, healthcare, communications and media, travel, and automotive.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.